A commentary putting the recent finerenone and spironolactone trials in perspective
The RADAR study - Visual Abstract
Are patients with rare kidney diseases different from other CKD? Check out the beautiful VAs by NSMC faculty Brian Rifkin and Cristina Popa
FLOW Trial: Are Innovative Treatments Accessible to the Patient Communities in Need?`
NOSTONE in Kidney Medicine
Our NephJC NOSTONE editorial in Kidney Medicine is live. Great work from Renz Palisan, Nikita Pawar, and Rasha Alawieh; supported by Swap and Jade.
Read it here.
NephJC Summer Book Club
Podcast on the Diuretic Comparison Project
The filtrate discuss chlorthalidone versus hydrochlorothiazide with the study author.
STOP-ACEi in Kidney Medicine
Our NephJC STOP-ACEi editorial in Kidney Medicine is live. Great work from Susan Thanabalasingam and Cristina Popa, supported by Nayan, Swap, and Jade.
Read it here.
Freely Filtered does MyTEMP
Episode 043: In this episode we chill out and discuss why it may not be necessary to make patients uncomfortably cool to prevent cardiovascular badness. The lead author Amit Garg joins us to break it down.
Apixaban for atrial fibrillation in dialysis: Visual Abstract for AXADIA-AFNET 8 Study
Apixaban for atrial fibrillation in dialysis: Visual Abstract for RENAL AF
The AskASN Chat: Follow up FAQs
SODIUM-HF in Kidney Medicine
The NephJC editorial in Kidney Medicine is live. Great work from Sheikh Khalid, Rachel Hung, and William Vasquez Espinosa, supported by Nayan, Joel, and Jamie.
Read it here.
Freely Filtered does STOP ACE
Episode 055: The Filtrate try to figure out STOP ACE with the assistance of Laurie Tomlinson.
The CARDINAL Visual Abstract
Does Bardoxolone help patients with Alport’s Syndrome? Dr M Abdul Qader explains graphically.
Freely Filtered does minimal change disease and anti-nephrin antibodies
Episode 042: Minimal change disease has classically been described as having negative immunofluorescence and to not be antibody mediated. But here comes Dr Weans with a fresh study smashing this orthodoxy. She proposes anti-nephrin antibodies as the etiologic agent driving minimal change disease.
Freely Filtered does Xenotransplantation
Episode 044: The University of Alabama with Revicor have made a better pig. Better for transplanting. And they transplanted a pair of these into a brain dead patient. The filtrate discuss the case report with transplant surgeon, Josh Mezrich.
Freely Filtered does SSaSS
Episode 045: Switching table salt to a blend of sodium and potassium chloride reduces stroke and improves total mortality. What’s not to like?
Freely Filtered does ISPD Peritonitis Guidelines
Episode 046: The Guideline Draft is back! This time the 2022 ISPD Peritonitis Guidelines are on the clock! The Filtrate are joined by PD junky Jade Teakell and guideline author, Jeff Perl.
Freely Filtered does CHAP
Episode 047: This is a guideline shredding study. This landmark study of blood pressure in pregnancy is going to change how we approach hypertension in pregnancy.
Freely Filtered does TESTING-2
Episode 048: TESTING is the latest IgA nephropathy trial and it is the comeback kid of nephrology trials. From a trial that was halted because of excess adverse events to a safe and effective therapy with just a few tweeks. Amazing turn around. Join the Filtrate as we put TESTING to the test with study author Sean Barbour.